Egle Pavyde

Egle Pavyde has a diverse and extensive work experience. Egle is currently the Director of Business Development, EMEA & APAC at hVIVO since April 2022. Prior to this, they held the role of Director of Business Development at Venn Life Sciences, which is part of hVIVO plc, starting in October 2022. In December 2022, Egle became the Gender Equality Working Group Coordinator at Association "Lyderė". Egle is also a Co-Founder of LONGEVERSE since December 2022.

Before these roles, Egle worked at Biomapas for several years, starting as the Regulatory Affairs Manager (Interim Head of Regulatory Affairs) from July 2015 to September 2016. Egle then took on various roles in business development, including Associate Director, Director, and Head of Business Development from 2017 to 2022. Egle also worked as a Lecturer of Pharmacology and a Junior Researcher at the Institute of Physiology and Pharmacology, Lithuanian University of Health Sciences from 2012 to 2015, where they were involved in research projects related to medicinal stem cell products and kidney regeneration.

Additionally, Egle had a role as the Director of Business Development at BIO1, an early-phase clinical trials unit located in Lithuania, from January 2019 to April 2022.

Egle Pavyde has an extensive education history. Egle obtained a Doctor of Pharmacy (PharmD) degree in Pharmacology from the Lithuanian University of Health Sciences in 2016. Egle also holds a Master's degree in Pharmacy from the same university, which they completed from 2008 to 2012.

In addition to their pharmacy education, Egle pursued further studies in different fields. In 2014, they were a PhD student researcher at the University of Pittsburgh, focusing on Stem Cell Research. In 2012, they completed a course in Laboratory Animal Science at Vilniaus universitetas / Vilnius University.

Egle also engaged in various courses and programs related to their career. In 2022, they took a course at Harvard Medical School on Immunology: Vaccines and Viral Immunology. Egle further developed their immunology knowledge at Rice University with a course on Fundamentals of Immunology in the same year. In 2021, they attended a course on Strategic Sales Management at Harvard University.

Egle has also obtained additional certifications. In 2017, they completed "MKTG101x: Introduction to Marketing: Tools to Set Enterprises Apart" from edX. Egle earned "SW25x: Global Health: Case Studies from a Biosocial Perspective" and "HSPH-HMS214x: Fundamentals of Clinical Trials" certifications from edX in 2014. In 2013, they completed "4.01x: Take Your Medicine - The Impact of Drug Development" from edX. Additionally, in 2013, they obtained the FELASA category C certification from Vilnius University, validating their skills and knowledge in laboratory animal science.

It is important to note that no further assumptions can be made about Egle Pavyde's education history beyond the information provided.